Geneos Wealth Management’s Innovator US Equity Buffer ETF March BMAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.4K Hold
320
– – ﹤0.01% 1831
2026
Q1
$16.8K Hold
320
– – ﹤0.01% 1836
2025
Q4
$17K Hold
320
– – ﹤0.01% 1792
2025
Q3
$16.5K Hold
320
– – ﹤0.01% 1797
2025
Q2
$15.7K Buy
320
+160
+100% +$7.4K ﹤0.01% 2139
2025
Q1
$7.29K Hold
160
– – ﹤0.01% 2390
2024
Q4
$7.38K Hold
160
– – ﹤0.01% 2181
2024
Q3
$7.2K Hold
160
– – ﹤0.01% 1948
2024
Q2
$6.91K Hold
160
– – ﹤0.01% 1635
2024
Q1
$6.67K Buy
+160
New +$6.49K ﹤0.01% 1650

Other funds holding BMAR

Geneos Wealth Management's BMAR Position: Q2 2026 in Review

Geneos Wealth Management held its Innovator US Equity Buffer ETF March (BMAR) position steady in Q2 2026 at 320 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1831.

Geneos Wealth Management first reported a position in BMAR in Q1 2024 and has held it in 10 quarters since. 107 funds tracked by Wall St. Rank hold BMAR as of Q2 2026.

  • Geneos Wealth Management held 320 shares of Innovator US Equity Buffer ETF March worth $18.4K as of Q2 2026.
  • Geneos Wealth Management left its Innovator US Equity Buffer ETF March share count unchanged in Q2 2026.
  • Innovator US Equity Buffer ETF March made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1831 holding.
  • Geneos Wealth Management first reported a position in Innovator US Equity Buffer ETF March in Q1 2024 and has held it in 10 quarters since.
  • 107 funds tracked by Wall St. Rank held Innovator US Equity Buffer ETF March as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.